CTXR Earnings

Quarterly EPS
$-1.59
Q4 2024
$-1.30
Q1 2025
$-1.27
Q2 2025
$-0.80
Q3 2025
$-0.46
Q4 2025
$-0.38
Q1 2026
$-0.95
Q2 2026
$-0.34
Q3 2026
Latest Revenue1.5M
Latest Net Income-11919260
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.341.5M-11919260—+57.5%
Q2 2026-$0.951.7M-28109746—+25.2%
Q1 2026-$0.383.9M-9393889—+70.8%
Q4 2025-$0.460-8743646—+71.1%
Q3 2025-$0.800-9203872—+49.0%
Q2 2025-$1.270-11511505—+5.2%
Q1 2025-$1.300-10281246—+10.3%
Q4 2024-$1.590-11077164—+9.1%
Q3 2024-$1.570-10573336——
Q2 2024-$1.340-8544154——
Q1 2024-$1.450-9231185——
Q4 2023-$1.750-9943910——
Citius Pharmaceuticals Inc. Common (CTXR) — Earnings